![]() |
Technical Data |
|
M9875-01D |
Myostatin Fusion Protein, Recombinant, Human, Propeptide (Lyophilized) (Growth Differentiation Factor 8, MSTN, gdf8) |
5ug 25ug 100ug |
| Growth Factors, Cytokines | Storage: -70°CShipping: Blue Ice |
|
Myostatin (GDF-8), a member of the TGFbeta superfamily, is a potent and specific negative regulator of skeletal muscle mass. In serum, myostatin circulates as part of a latent complex containing myostatin propeptide and/or follistatin-related gene. The myostatin propeptide is known to bind and inhibit myostatin in vitro. This interaction is relevant in vivo, with a majority (>70%) of myostatin in serum bound to its propeptide. The myostatin propeptide is negative regulator of myostatin in vivo. AA Sequence: MNENSEQKEN VEKEGLCNAC TWRQNTKSSR IEAIKIQILS KLRLETAPNI SKDVIRQLLP KAPPLRELID QYDVQRDDSS DGSLEDDDYH ATTETIITMP TESDFLMQVD GKPKCCFFKF SSKIQYNKVV KAQLWIYLRP VETPTTVFVQ ILRLIKPMKD GTRYTGIRSL KLDMNPGTGI WQSIDVKTVL QNWLKQPESN LGIEIKALDE NGHDLAVTFP GPGEDGLNPF LEVKVTDTPK RSRR Storage and Stability: Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with 20mM HCL, 0.1% BSA or HSA. Aliquot and store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. Molecular Weight: 27.8kD |
Source: Recombinant, human, E. coli Purity: 95% as determined by RP-HPLC; Reducing and non-reducing SDS-PAGE. Endotoxin: 0.01ng/ug or <0.1EU/ug (LAL) Form: Supplied as a lyophilized powder. Reconstitute with sterile 20mM HCL, 0.1% BSA or HSA to 0.1-1mg/ml, which can be further diluted into other aqueous solutions. Specificity: Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
|
|
||